A forensic read on Fuller H B Co built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Safe
Financial health
2.9
Distress distance
Clean
Earnings quality
4
Forensic signals
7.9%
ROE
-2.7%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Fuller H B Co earns a B (Sound & dependable) forensic quality grade, and its balance-sheet distress test reads 2.9, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
5.7%
FY2025
Return on invested capital.Return on invested capital is 5.7% in the latest fiscal year and steady across FY2023–FY2025, inside a 0.4-point range. After-tax operating profit was $231M in FY2023 and $240M in FY2025, with operating income at 10.1% of revenue in FY2023 and 9.8% in FY2024. The capital base behind it went from $3.9B in FY2023 to $4.2B in FY2025 (+9%), while the revenue it carried went from $3.5B to $3.5B. Across FY2024–FY2025, $722M went into capital expenditure and acquisitions against $183M of depreciation excluding $170M of intangible-asset amortisation. The base is struck net of amortisation, write-downs and the current liabilities that fund it, so it moved by less than that spending net of the wear, and this row does not say which of those absorbed the difference. FY2024's operating profit carried a $32M goodwill write-off and a $22M restructuring charge that alone took about 0.9 points off that year's return; FY2024 sits between the two ends of FY2023–FY2025, so the charge shapes the path between them without moving the change across it. A non-cash write-down lowers the reported return in the year it lands.
$32M
FY2024
Goodwill impairments.Took $32M of goodwill writedowns across 1 year (FY2024 ($32M)) — about 25% of net income over the span. A large writedown means an acquisition turned out worth far less than was paid — a real mark against M&A discipline.
72d
FY2024→FY2025
Inventory days.Days inventory outstanding moved from 66 to 72 FY2024→FY2025 (against cost of goods sold; inventory +1% vs -5% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
92% of FCF
FY2025
Shareholder returns.Returned $111M to shareholders (buybacks + dividends) in FY2025 — 92% of free cash flow. Right at the limit of what free cash flow covers — little room before it's funded by debt or the balance sheet. That ratio has been CLIMBING toward the limit — 18% of free cash flow two years back — not just sitting there. Counting the $22M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 110%.
Key fundamentals
Latest Revenue$3.47B
Revenue Growth YoY-2.7%
Revenue CAGR (2yr)-0.5%
Net Margin4.4%
Free Cash Flow$121.2M
Return on Equity7.9%
Debt / Equity1.01x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Fuller H B Co's actual 10-K/10-Q/8-K filings?